“Helping address unmet medical need through the development of novel science that delivers products which treat these afflictions is both challenging and rewarding.  It’s at the heart of what motives me to work in Biotechnology and to support emerging Entrepreneurs in building new companies.”

John A. Latham, PhD


Dr. John Latham has over 30 years’ experience in senior scientific management roles. Dr. Latham most recently served as Chief Scientific Officer and co-Founder at Alder BioPharmaceuticals. Prior to this, he served as a director, senior director, and Vice President of Gene Function and Target Validation for Celltech Group plc. Dr. Latham joined Darwin Molecular Corporation as a founding director and joined Gilead Sciences, Inc. as one of its earliest scientists.

Dr. Latham holds a Ph.D. in Biochemistry from Massachusetts Institute of Technology and a B.S. in Chemistry from Colorado State University.